Braden's study demonstrated that myeloid cells lacking SOCS3 expression exhibit augmented and sustained production of proinflammatory M1-type cytokines upon exposure to glioma-derived conditioned media in vitro. The gene discussed is SOCS3; the disease is central nervous system cancer.